|
Diagnosis after-LEEP, n
|
Positive RM, n (%)
|
Residual disease, n (%)
|
|---|
|
CIN1, 70
|
0
|
0
|
|
CIN2/3, 290
|
44 (15.2)
|
1 (0.3)
|
|
Endocervix 25a
|
1 (CIN3, LEEP at 4 mo)
|
|
Exocervix 18a
|
0
|
|
Both margins 1a
|
0
|
|
AIS, 5
|
1 (20.0)
|
0
|
|
Endocervix 1b
|
0
|
|
Exocervix 0
| |
|
Both margins 0
| |
|
Microinvasive SCC, 13
|
8 (61.5)
|
2 (15.4)
|
|
Endocervix 5
|
1b (microinvasive SCC)
|
|
Exocervix 0
| |
|
Both margins 3
|
1b (invasive SCC)
|
|
Invasive SCC, 3
|
3 (100.0)
|
0
|
|
Endocervix 2c
|
0
|
|
Exocervix 0
| |
|
Both margins 1c
|
0
|
- LEEP loop electrosurgical excision procedure, RM resection margin, CIN cervical intraepithelial neoplasia, AIS adenocarcinoma in-situ, SCC squamous cell carcinoma
- afollow-up without additional LEEP (pap smear, HPV DNA testing and endocervical curettage at 4–6 months);
- bhysterectomy
- cradical hysterectomy, radical trachelectomy
